Abstract:In a systematic effort to identify a potent anticancer agent, we synthesized 15 oxovanadium(IV) complexes and examined their cytotoxic activity against 14 different human cancer cell lines. The oxovanadium compounds included mono and bis ancillary ligands of 1,10-phenanthroline (phen) [VO(phen), VO(phen)2, VO(Me2-phen), VO (Me2-phen)2, VO(Cl-phen), VO(Cl-phen)2, VO(NO2-phen), VO(NO2-phen)2], 2,2'-bipyridyl (bipy) [VO(bipy), VO(bipy)2, VO(Me2-bipy), VO(Me2-bipy)2], and 2-2'-bipyrimidine(bipym) [VO(bipym) and VO-(bipym)2], linked via nitrogen atoms, and 5'-bromo-2'-hydroxyacetophenone (acph) [VO(acph)2], linked via oxygen donor atom. The mono-chelated [VO(Me2-phen), compound 3] and bis-chelated-phen[VO(Me2-phen)2, compound 4] complexes were the most potent oxovanadium compounds and killed target cancer cells at low micromolar concentrations. Notably, the dimethyl substitution of the phenanthroline rings was essential for the anticancer activity of both compound 4 [VO(Me2-phen)2] and compound 3 [VO(Me2-phen)] because unsubstituted bis-chelated and mono-chelated phen oxovanadium(IV) complexes [VO(phen), compound 1, or VO(phen)2, compound 2] were less active. Addition of a chloro or nitro group to the phen complexes did not significantly improve the cytotoxic activity of the unsubstituted oxovanadium(IV) complexes. Irrespective of the ligands, bis-chelated phenanthroline containing compounds showed better activity than the mono-chelated phenanthroline containing complexes. The marked differences in the cytotoxic activity of oxovanadium(IV) complexes containing different heterocyclic ancillary ligands suggest that the cytotoxic activity of these compounds is determined by the identity of the five-member bidentate ligands, as well as the nature of the substitutents on the heterocyclic aromatic rings. Our results presented herein provide experimental evidence that oxovanadium compounds induce apoptosis in human cancer cells. Oxovanadium compounds, especially the lead compound VO(Me2-phen)2, may be useful in the treatment of cancer.

Synthesis, X-ray Structure, and Anti-Leukemic Activity of Oxovanadium(iv) Complexes.

Bis(4,7-Dimethyl-1,10-Phenanthroline) Sulfatooxovanadium(Iv) As A Novel Apoptosis-Inducing Anticancer Agent

Oxovanadium Phenanthroimidazole Derivatives: Synthesis, DNA Binding and Antitumor Activities

Synthesis,in Vitrocytotoxicity, and Structure–activity Relationships (SAR) of Multidentate Oxidovanadium(iv) Complexes As Anticancer Agents

Exploring Anticancer Activities and Structure–Activity Relationships of Binuclear Oxidovanadium(IV) Complexes

New Oxidovanadium Complexes Incorporating Thiosemicarbazones And 1, 10-Phenanthroline Derivatives As Dna Cleavage, Potential Anticancer Agents, And Hydroxyl Radical Scavenger

New Oxidovanadium Complexes Incorporating Thiosemicarbazones and 1, 10‐phenanthroline Derivatives As DNA Cleavage, Potential Anticancer Agents, and Hydroxyl Radical Scavenger

Synthesis, crystal structure and DNA interaction of a new oxovanadium (IV) complex with ligands of L-tyrosine schiff base and 1, 10-phenanthroline

Synthesis, Crystal Structures, DNA Binding and Cleavage Studies of Two Oxovanadium(iv) Complexes of 1,10-Phenanthroline and Schiff Bases Derived from Tryptophan

High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Exploring the Antitumor Efficacy of N-Heterocyclic Nitrilotriacetate Oxidovanadium(IV) Salts on Prostate and Breast Cancer Cells

Synthesis, Crystal Structure, and DNA Interaction of an Oxovanadium(iv) Complex Containing L-valine Schiff Base and 1,10-Phenanthroline

The anti-tumor activity of novel oxovanadium complexes derived from thiosemicarbazones and fluoro-phenanthroline derivatives

Synthesis, Spectral and Antiferromagnetic Interaction in Oxalato-Bridged Linear Trinuclear Oxovanadium(Iv) Complexes

Novel Oxovanadium Complex VO(hntdtsc)(NPIP): Anticancer Activity and Mechanism of Action on HeLa Cells.

Synthesis, Characterization and Crystal Structure of Oxovanadium(V) Complex Derived from 2-Bromo-4-chloro-6-((2-(ethylamino)ethylimino)methyl)phenol

Vanadium(v) complexes derived from triphenylphosphonium and hydrazides: cytotoxicity evaluation and interaction with biomolecules

Synthesis, Characterization and Magnetic Properties of Binuclear Oxovanadium(IV) Complexes with A. Bromanilate Bridge

An Unexpected Oxovanadium(iv) Complex with in Situ Generated Lactone Ligand: Synthesis, Crystal Structure and DNA-binding Property

Synthesis, Characterization, and Crystal Structures of New Oxovanadium(V) Complexes with Mixed Nicotinohydrazone and 8-Hydroxyquinoline Ligands